 MD News | Bellicum Announces Publication in The New England Journal of Medicine ... PR Newswire (press release) CaspaCIDeā¢ DLI is a donor lymphocyte infusion administered following a hematopoietic stem cell transplant, in which the safety switch may be activated to resolve graft-versus-host disease (GVHD). For more information, visit www.bellicum.com. Bellicum Announces Publication in The New England Journal of Medicine ... |
